{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "8593441", "DateCompleted": {"Year": "1996", "Month": "04", "Day": "08"}, "DateRevised": {"Year": "2019", "Month": "07", "Day": "19"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0918-6158", "JournalIssue": {"Volume": "18", "Issue": "10", "PubDate": {"Year": "1995", "Month": "Oct"}}, "Title": "Biological & pharmaceutical bulletin", "ISOAbbreviation": "Biol Pharm Bull"}, "ArticleTitle": "Inhibitory effect of isoliquiritin, a compound in licorice root, on angiogenesis in vivo and tube formation in vitro.", "Pagination": {"StartPage": "1382", "EndPage": "1386", "MedlinePgn": "1382-6"}, "Abstract": {"AbstractText": ["A water extract of licorice root inhibits granuloma angiogenesis in adjuvant-induced chronic inflammation (Phytother. Res., 5, 195. 1991). The present study has investigated the effects of licorice-derived compounds on granuloma angiogenesis. Isoliquiritin (0.31-3.1 mg/kg), a licorice-derived flavonoid, inhibited the carmine content of granuloma tissue 50-fold greater than licorice extract. Glyeyrrhizin (20-80 mg/kg), a licorice-derived saponin, inhibited carmine content with a weak potency. The licorice extract (0.01-1 mg/ml) also inhibited tube formation from vascular endothelial cells in a concentration-dependent manner. From the chemical structure-activities of used licorice-derived flavonoids (0.1-100 microM), their potencies for anti-tube formation were in the order isoliquiritigenin > isoliquiritin > liquiritigenin >> isoliquiritin-apioside. Glycyrrhizin (0.1-100 microM) and glycyrrhetinic acid (0.1-10 microM) increased tube formation. A glycyrrhizin (82 micrograms/ml)-induced increase in tube formation was inhibited by isoliquiritin. The combined effect of a mixture of 82 micrograms/ml glycyrrhizin and 4.2 micrograms/ml isoliquiritin, a similar concentration ratio to their yield ratio in the licorice extract, corresponded to the effect of 100 micrograms/ml extract. In conclusion, the anti-angiogenic effect of licorice extract depended on the anti-tube formation effect of isoliquiritin."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University, Japan."}], "LastName": "Kobayashi", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Miyamoto", "ForeName": "T", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Kimura", "ForeName": "I", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Kimura", "ForeName": "M", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Japan", "MedlineTA": "Biol Pharm Bull", "NlmUniqueID": "9311984", "ISSNLinking": "0918-6158"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents, Non-Steroidal"}, {"RegistryNumber": "0", "NameOfSubstance": "Glucosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "2Y348H1V4W", "NameOfSubstance": "neoisoliquiritin"}, {"RegistryNumber": "5S5A2Q39HX", "NameOfSubstance": "Chalcone"}, {"RegistryNumber": "6FO62043WK", "NameOfSubstance": "Glycyrrhizic Acid"}, {"RegistryNumber": "P540XA09DR", "NameOfSubstance": "Glycyrrhetinic Acid"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Inflammatory Agents, Non-Steroidal"}, {"QualifierName": ["cytology", "drug effects", "metabolism"], "DescriptorName": "Aorta, Thoracic"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": ["analogs & derivatives", "pharmacology"], "DescriptorName": "Chalcone"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Glucosides"}, {"QualifierName": ["analogs & derivatives", "pharmacology"], "DescriptorName": "Glycyrrhetinic Acid"}, {"QualifierName": ["chemistry"], "DescriptorName": "Glycyrrhiza"}, {"QualifierName": [], "DescriptorName": "Glycyrrhizic Acid"}, {"QualifierName": ["pathology"], "DescriptorName": "Granuloma"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred Strains"}, {"QualifierName": ["drug effects"], "DescriptorName": "Microtubules"}, {"QualifierName": ["pathology", "prevention & control"], "DescriptorName": "Neovascularization, Pathologic"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1995", "Month": "10", "Day": "1"}, {"Year": "1995", "Month": "10", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1995", "Month": "10", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["8593441", "10.1248/bpb.18.1382"]}}]}